<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: recurrence</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Women with breast cancer who consume soy food have lower risk of cancer recurrence</title>
   	 <description>Although there is a concern regarding the safety of soy food consumption among breast cancer survivors, researchers have found that women in China who had breast cancer and a higher intake of soy food had an associated lower risk of death and breast cancer recurrence, according to a study in the December 9 issue of JAMA. </description>
     <link>http://www.physorg.com/news179513192.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 08 Dec 2009 16:46:59 EST</pubDate>
	 <guid isPermaLink="false">news179513192</guid>
</item>
<item>
     <title>Detecting the Undetectable in Prostate Cancer Testing</title>
   	 <description>(PhysOrg.com) -- A team of Northwestern University researchers, using an extremely sensitive nanotechnology-based tool known as the biobarcode system, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. This new assay, just one of many being developed by investigators at the Nanomaterials for Cancer Diagnostics and Therapeutics Center for Cancer Nanotechnology Excellence (Northwestern CCNE), is 300 times more sensitive than commercially available PSA tests.</description>
     <link>http://www.physorg.com/news177775224.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Wed, 18 Nov 2009 14:50:01 EST</pubDate>
	 <guid isPermaLink="false">news177775224</guid>
</item>
<item>
     <title>Detecting the undetectable in prostate cancer screening</title>
   	 <description>A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.</description>
     <link>http://www.physorg.com/news175188038.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 19 Oct 2009 18:20:05 EST</pubDate>
	 <guid isPermaLink="false">news175188038</guid>
</item>
<item>
     <title>Study examines mastectomy and breast-conserving surgery rates</title>
   	 <description>There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study found that breast-conserving surgery was presented and provided in the majority of patients evaluated. Surgeon recommendations, patient decisions, and failure of breast-conserving surgery were all found to be contributing factors to the mastectomy rate. The findings are published in the October 14 issue of the Journal of the American Medical Association (JAMA), a theme issue on surgical care.</description>
     <link>http://www.physorg.com/news174661234.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 13 Oct 2009 14:50:05 EST</pubDate>
	 <guid isPermaLink="false">news174661234</guid>
</item>
<item>
     <title>Prediction model superior to traditional criteria in bladder treatment decision</title>
   	 <description>A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy. The analysis, to be published in the December 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, concludes that the model, which considers both how far the cancer has spread and other information, such as how the cancer cells look under the microscope and the time between diagnosis and surgery, could better identify patients who need to undergo further treatment.</description>
     <link>http://www.physorg.com/news174545519.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Oct 2009 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news174545519</guid>
</item>
<item>
     <title>Obesity increases risk of prostate cancer recurrence for both blacks and whites</title>
   	 <description>A new look at a large database of prostate cancer patients shows that obesity plays no favorites when it comes to increasing the risk of recurrence after surgery: Being way overweight is equally bad for blacks and whites, say researchers at Duke University Medical Center.</description>
     <link>http://www.physorg.com/news169403980.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 13 Aug 2009 18:00:03 EST</pubDate>
	 <guid isPermaLink="false">news169403980</guid>
</item>
<item>
     <title>Forecasting cancer recurrence</title>
   	 <description>Two people with the same kind of cancer who receive the exact same treatment may nevertheless have different chances of their tumors coming back years later. Now a team of scientists has developed a computer model that predicts cancer recurrence in an individual based on how her tumor changes size in response to the first rounds of radiation therapy.</description>
     <link>http://www.physorg.com/news168016968.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Jul 2009 16:23:00 EST</pubDate>
	 <guid isPermaLink="false">news168016968</guid>
</item>
<item>
     <title>Chemotherapy combination outcomes differ for aged, younger colon cancer patients</title>
   	 <description>ORLANDO, Fla.--The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 -- but not for those who are older, according to Mayo Clinic and Dana-Farber Cancer Institute scientists who will present their findings at the American Society of Clinical Oncology's (ASCO) annual meeting in Orlando, Fla.</description>
     <link>http://www.physorg.com/news162813755.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 11:03:09 EST</pubDate>
	 <guid isPermaLink="false">news162813755</guid>
</item>
<item>
     <title>Cottonseed-based drug shows promise in treating severe brain cancer</title>
   	 <description>An experimental drug derived from cottonseed shows promise in treating the recurrence of glioblastoma multiforme, widely considered the most lethal brain cancer, said researchers at the University of Alabama at Birmingham (UAB).</description>
     <link>http://www.physorg.com/news162725213.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 May 2009 10:31:50 EST</pubDate>
	 <guid isPermaLink="false">news162725213</guid>
</item>
<item>
     <title>Long-term study shows low oxygen levels in prostate tumors can predict recurrence</title>
   	 <description>Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer. The long-term study results will be presented at the 2009 American Society of Clinical Oncology annual meeting in Orlando, FL.</description>
     <link>http://www.physorg.com/news161629517.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 15 May 2009 18:05:36 EST</pubDate>
	 <guid isPermaLink="false">news161629517</guid>
</item>
<item>
     <title>Test may help predict colon cancer recurrence risk</title>
   	 <description>A new gene test may help predict which colon cancer patients are at higher or lower risk of having their cancer return after surgery, doctors report, but whether it is useful enough to justify its likely high price remains to be seen.</description>
     <link>http://www.physorg.com/news161544138.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 14 May 2009 18:22:49 EST</pubDate>
	 <guid isPermaLink="false">news161544138</guid>
</item>
<item>
     <title>New universal breast cancer marker predicts recurrence and clinical outcome</title>
   	 <description>Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.</description>
     <link>http://www.physorg.com/news160833169.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 06 May 2009 12:54:10 EST</pubDate>
	 <guid isPermaLink="false">news160833169</guid>
</item>
<item>
     <title>New gene may provide breast cancer diagnostic marker</title>
   	 <description>In a research article published in this week's PLoS Medicine, Ann Killary (from the University of Texas M. D. Anderson Cancer Center) and colleagues describe a new gene called DEAR1 that is genetically altered by mutation and deletion in breast tumors, and that may provide a new breast cancer prognostic marker.</description>
     <link>http://www.physorg.com/news160724140.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 05 May 2009 06:36:04 EST</pubDate>
	 <guid isPermaLink="false">news160724140</guid>
</item>
<item>
     <title>Researchers identify genetic markers for aggressive head and neck cancer</title>
   	 <description>Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer. These findings could one day lead to a genetic test that could help select or predict successful treatment options for patients with this type of cancer. The results were published in the American Journal of Pathology.</description>
     <link>http://www.physorg.com/news156619491.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Mar 2009 18:25:25 EST</pubDate>
	 <guid isPermaLink="false">news156619491</guid>
</item>
<item>
     <title>Cancer recurrence fears 'overlooked'</title>
   	 <description>(PhysOrg.com) -- The anxiety of cancer returning is often overlooked by both patients and medics, according to leading experts in the disease.  </description>
     <link>http://www.physorg.com/news154714235.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 24 Feb 2009 16:11:10 EST</pubDate>
	 <guid isPermaLink="false">news154714235</guid>
</item>
<item>
     <title>Biomarker predicts disease recurrence in colorectal cancer</title>
   	 <description>Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.</description>
     <link>http://www.physorg.com/news154116671.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Feb 2009 18:12:03 EST</pubDate>
	 <guid isPermaLink="false">news154116671</guid>
</item>
<item>
     <title>Early stage, HER2-positive breast cancer patients at increased risk of recurrence</title>
   	 <description>Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://www.physorg.com/news148315554.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 12 Dec 2008 14:45:54 EST</pubDate>
	 <guid isPermaLink="false">news148315554</guid>
</item>
<item>
     <title>Meta-analyses of global trials finds in favor of aromatase inhibitors</title>
   	 <description>Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back. Patients using aromatase inhibitors had more than a 3 percent lower cancer recurrence 6-8 years after diagnosis, compared to women using tamoxifen alone.</description>
     <link>http://www.physorg.com/news148236483.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 11 Dec 2008 16:48:03 EST</pubDate>
	 <guid isPermaLink="false">news148236483</guid>
</item>
<item>
     <title>Protein levels indicate risk of death in some colorectal cancer patients</title>
   	 <description>A pair of proteins may help explain why people with surgically removed colorectal cancer and who are overweight, physically inactive, and follow a Western-pattern diet may have an increased risk of dying of the disease or other causes, Dana-Farber Cancer Institute scientists report in a new study.</description>
     <link>http://www.physorg.com/news148057346.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 09 Dec 2008 15:02:26 EST</pubDate>
	 <guid isPermaLink="false">news148057346</guid>
</item>
<item>
     <title>Restless nights put older adults at risk for depression recurrence</title>
   	 <description>Nearly 60 percent of the nation's elderly have trouble sleeping, whether it's a lot of tossing and turning or outright bouts of insomnia. While for most people sleeplessness can be annoying at best or unhealthy at worst, for elderly individuals who have suffered from depression in the past, poor sleep may be the first sign that a new bout of depression is coming on.</description>
     <link>http://www.physorg.com/news141994900.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 30 Sep 2008 12:01:40 EST</pubDate>
	 <guid isPermaLink="false">news141994900</guid>
</item>
<item>
     <title>Young women w/ early form of breast cancer no more likely to experience recurrence than older women</title>
   	 <description>Young women with DCIS, a common form of early breast cancer that arises in and is confined to the mammary ducts, are presumed more likely to have recurrences than older women with the same diagnosis.  But a new study from Fox Chase Cancer Center rebuffs this conventional thinking.</description>
     <link>http://www.physorg.com/news141483264.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 24 Sep 2008 13:54:24 EST</pubDate>
	 <guid isPermaLink="false">news141483264</guid>
</item>
<item>
     <title>Risk assessment plays key role in long-term treatment of breast cancer</title>
   	 <description>Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news137772149.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 12 Aug 2008 15:02:29 EST</pubDate>
	 <guid isPermaLink="false">news137772149</guid>
</item>
<item>
     <title>Treating rare breast cancer with radiation therapy may lower recurrence rate</title>
   	 <description>Patients with a rare type of breast cancer may benefit from receiving radiation therapy in addition to surgery to prevent recurrence, according to a study in the July issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.</description>
     <link>http://www.physorg.com/news134995950.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 11 Jul 2008 11:52:30 EST</pubDate>
	 <guid isPermaLink="false">news134995950</guid>
</item>


</channel>
</rss>

